Journal of Clinical Pharmacy and Therapeutics 2017-Oct
Cure with ledipasvir/sofosbuvir for chronic hepatitis C virus in an individual with gastric bypass.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Il collegamento viene salvato negli appunti
Parole chiave
Astratto
OBJECTIVE
The impact of gastric bypass surgery on the pharmacokinetics of various medications has been reported. Presently, no data exist for the treatment of chronic hepatitis C virus with ledipasvir/sofosbuvir (LDV/SOF) in an individual with a history of gastric bypass.
METHODS
We report the successful cure of an individual who was treated with LDV/SOF who had a history of gastric bypass. The patient tolerated LDV/SOF well while only experiencing a minor headache.
CONCLUSIONS
Ledipasvir/sofosbuvir treatment may still be effective in those with a history of gastric bypass surgery.
